Eli Lilly to Present on Risk-based Monitoring Data Strategy, March 12th

Wednesday, February 25, 2015

Don’t miss Eli Lilly’s presentation on metrics and data usage to assess protocol-level risk before, during and after a study. This WebEx will be led by Nancy Dynes, Consultant, Global Medical Quality Metrics at Eli Lilly, and discussion topics will include:

• RBM data perspective

• How to use data to prepare for RBM in a trial

• How to use data to monitor the RBM process across trials

Presentation date and time: Thursday, March 12th, at 11 a.m. EST

*Please note: this presentation will not be recorded.

This presentation is open to members only.

Please log on to the MCC Member Portal or email customerservice@metricschampion.org for registration details.